Lene H S Veiga (Lene Veiga)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Acute Heart Failure

Epidermal Growth Factor Receptor

Cardiovascular Disease

Top Venues

Journal of the National Cancer Institute

Breast cancer research and treatment

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Karina B Ribeiro, Lene H S Veiga, Nevicolino P Carvalho Filho, Lindsay M Morton, Ruth A Kleinerman, Célia B G Antoneli
Overall survival and cause-specific mortality in a hospital-based cohort of retinoblastoma patients in São Paulo, Brazil. International journal of cancer (2024)
Jacqueline B Vo, Cody Ramin, Lene H S Veiga, Carolyn Brandt, Rochelle E Curtis, Clara Bodelon, Ana Barac, Véronique L Roger, Heather Spencer Feigelson, Diana S M Buist, Erin J Aiello Bowles, Gretchen L Gierach, Amy Berrington de González
Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors. Journal of the National Cancer Institute 116 (8) (2024)
Jacqueline B Vo, Cody Ramin, Lene H S Veiga, Carolyn Brandt, Rochelle E Curtis, Clara Bodelon, Ana Barac, Véronique L Roger, Heather Spencer Feigelson, Diana S M Buist, Erin J Aiello Bowles, Gretchen L Gierach, Amy Berrington de González
Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors. Journal of the National Cancer Institute 116 (8) (2024)
Jacqueline B Vo, Cody Ramin, Lene H S Veiga, Carolyn Brandt, Rochelle E Curtis, Clara Bodelon, Ana Barac, Véronique L Roger, Heather Spencer Feigelson, Diana S M Buist, Erin J Aiello Bowles, Gretchen L Gierach, Amy Berrington de González
Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors. Journal of the National Cancer Institute 116 (8) (2024)
Jacqueline B Vo, Cody Ramin, Ana Barac, Amy Berrington de González, Lene H S Veiga
Trends in heart disease mortality among breast cancer survivors in the US, 1975-2017. Breast cancer research and treatment 192 (3) (2022)